Prices delayed by at least 15 minutes | Print
Fusion Antibodies PLC (FAB)
ORD 4PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Fusion Antibodies PLC is a Contract Research Organisation (CRO) providing antibody identification, engineering, and expression services for the discovery and development of antibodies for human and veterinary therapeutics, as well as for diagnostics. Its customers are pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company's three core service areas include: Discovery (identification, screening, and sequencing of novel antibodies); Engineering (optimising the performance of antibodies); and Supply (production and purification of antibodies for further development). Geographically company generates the majority of its revenue from North America and the Rest of the World, followed by the United Kingdom and the Rest of Europe.
Address
30 Victoria Street, C/O Tughans Solicitors
Marlborough House
Belfast
GBR
BT1 3GS
Telephone
+44 2890432800
Forecast key dates
| Name | Key Date |
|---|---|
| Fusion Antibodies PLC Second Quarter Earnings Conference Call for 2027 | 2026-11-25T11:00:00 |
| Fusion Antibodies PLC Second Quarter Earnings Results for 2027 | 2026-11-24T00:00:00 |
| Fusion Antibodies PLC Annual General Meeting for 2026 | 2026-10-16T10:00:00 |
| Fusion Antibodies PLC Annual Report for 2026 | 2026-09-18T00:00:00 |
| Fusion Antibodies PLC Fourth Quarter Earnings Conference Call for 2026 | 2026-09-15T10:00:00 |
| Fusion Antibodies PLC Fourth Quarter Earnings Results for 2026 | 2026-09-04T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Fusion Antibodies PLC Second Quarter Earnings Conference Call for 2026 | 2025-11-25T11:00:00 |
| Fusion Antibodies PLC Second Quarter Earnings Results for 2026 | 2025-11-24T00:00:00 |
| Fusion Antibodies PLC Annual General Meeting for 2025 | 2025-10-16T10:00:00 |
| Fusion Antibodies PLC Annual Report for 2025 | 2025-09-19T00:00:00 |
| Fusion Antibodies PLC Fourth Quarter Earnings Conference Call for 2025 | 2025-09-15T10:00:00 |
| Fusion Antibodies PLC Fourth Quarter Earnings Results for 2025 | 2025-09-04T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.